MRVT — Miravant Medical Technologies Income Statement
0.000.00%
Last trade - 00:00HealthcareHighly SpeculativeMicro Cap
- $0.00m
- $13.02m
Annual income statement for Miravant Medical Technologies, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
C2000 December 31st | C2001 December 31st | 2002 December 31st | 2003 December 31st | 2004 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 4.59 | 4.68 | 0.499 | 0 | 0 |
| Cost of Revenue | |||||
| Gross Profit | 4.59 | 3.75 | 0.02 | 0 | 0 |
| Selling / General / Administrative Expenses | |||||
| Research And Development | |||||
| Unusual Expense / Income | |||||
| Total Operating Expenses | 26.2 | 20.3 | 15.8 | 3.15 | 13.1 |
| Operating Profit | -21.6 | -15.6 | -15.3 | -3.15 | -13.1 |
| Gain / Loss on Sale of Assets | |||||
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | -26 | -16.4 | -16 | -7.46 | -15.9 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | -26 | -16.4 | -16 | -7.46 | -15.9 |
| Net Income Before Extraordinary Items | |||||
| Net Income | -26 | -16.4 | -16 | -7.46 | -15.9 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Dilution Adjustment | |||||
| Diluted Net Income | -26 | -16.4 | -16 | -7.46 | -15.9 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | -1.42 | -0.911 | -0.776 | -0.672 | -0.484 |
| Dividends per Share |